{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T23:16:28Z","timestamp":1789773388637,"version":"4.0.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,3,2]],"date-time":"2021-03-02T00:00:00Z","timestamp":1614643200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,2]],"date-time":"2021-03-02T00:00:00Z","timestamp":1614643200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001646","name":"Robert-Bosch Stiftung","doi-asserted-by":"crossref","award":["Project O3"],"award-info":[{"award-number":["Project O3"]}],"id":[{"id":"10.13039\/501100001646","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1007\/s00428-021-03050-4","type":"journal-article","created":{"date-parts":[[2021,3,2]],"date-time":"2021-03-02T23:02:16Z","timestamp":1614726136000},"page":"575-583","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["The \u201cBurkitt-like\u201d immunophenotype and genotype is rarely encountered in diffuse large B cell lymphoma and high-grade B cell lymphoma, NOS"],"prefix":"10.1007","volume":"479","author":[{"given":"Katrin S.","family":"H\u00fcttl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette M.","family":"Staiger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Richter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Michaela","family":"Ott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Kalmbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfram","family":"Klapper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Sophie","family":"Biesdorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenz","family":"Tr\u00fcmper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Rosenwald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marita","family":"Ziepert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heike","family":"Horn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"German","family":"Ott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,2]]},"reference":[{"key":"3050_CR1","unstructured":"Swerdlow SH, Campo E, Harris NL et al (eds) (2017) WHO classification of tumours of haematopoietic and lymphoid tissues, Revised 4th edition. World Health Organization classification of tumours. International Agency for Research on Cancer, Lyon"},{"issue":"4","key":"3050_CR2","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1093\/oxfordjournals.annonc.a057938","volume":"2","author":"S Roithmann","year":"1991","unstructured":"Roithmann S, Toledano M, Tourani JM, Raphael M, Gentilini M, Gastaut JA, Armengaud M, Morlat P, Tilly H, Dupont B (1991) HIV-associated non-Hodgkin\u2019s lymphomas: Clinical characteristics and outcome. The experience of the French Registry of HIV-associated tumors. Ann Oncol 2(4):289\u2013295. https:\/\/doi.org\/10.1093\/oxfordjournals.annonc.a057938","journal-title":"Ann Oncol"},{"issue":"6","key":"3050_CR3","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1111\/j.1365-2559.2003.01758.x","volume":"43","author":"L de Leval","year":"2003","unstructured":"de Leval L, Harris NL (2003) Variability in immunophenotype in diffuse large B-cell lymphoma and its clinical relevance. Histopathology 43(6):509\u2013528. https:\/\/doi.org\/10.1111\/j.1365-2559.2003.01758.x","journal-title":"Histopathology"},{"issue":"1","key":"3050_CR4","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1182\/blood.V90.1.244","volume":"90","author":"RD Gascoyne","year":"1997","unstructured":"Gascoyne RD, Adomat SA, Krajewski S, Krajewska M, Horsman DE, Tolcher AW, O\u2019Reilly SE, Hoskins P, Coldman AJ, Reed JC, Connors JM (1997) Prognostic significance of Bcl-2 protein expression and Bcl-2 gene rearrangement in diffuse aggressive non-Hodgkin\u2019s lymphoma. Blood 90(1):244\u2013251","journal-title":"Blood"},{"issue":"1","key":"3050_CR5","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1182\/blood.V87.1.265.265","volume":"87","author":"O Hermine","year":"1996","unstructured":"Hermine O, Haioun C, Lepage E, d\u2019Agay MF, Briere J, Lavignac C, Fillet G, Salles G, Marolleau JP, Diebold J, Reyas F, Gaulard P (1996) Prognostic significance of bcl-2 protein expression in aggressive non-Hodgkin\u2019s lymphoma. Groupe d\u2019Etude des Lymphomes de l\u2019Adulte (GELA). Blood 87(1):265\u2013272","journal-title":"Blood"},{"issue":"6","key":"3050_CR6","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1200\/JCO.2005.03.4264","volume":"24","author":"J Iqbal","year":"2006","unstructured":"Iqbal J, Neppalli VT, Wright G, Dave BJ, Horsman DE, Rosenwald A, Lynch J, Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Campo E, Ott G, M\u00fcller-Hermelink HK, Delabie J, Jaffe ES, Grogan TM, Connors JM, Vose JM, Armitage JO, Staudt LM, Chan WC (2006) BCL2 expression is a prognostic marker for the activated B-cell-like type of diffuse large B-cell lymphoma. J Clin Oncol 24(6):961\u2013968. https:\/\/doi.org\/10.1200\/JCO.2005.03.4264","journal-title":"J Clin Oncol"},{"key":"3050_CR7","volume-title":"WHO classification of Tumours of Haematopoetic and Lymphoid Tissues","author":"SH Swerdlow","year":"2008","unstructured":"Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (2008) WHO classification of Tumours of Haematopoetic and Lymphoid Tissues. IARC Press Lyon, France"},{"issue":"2","key":"3050_CR8","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1038\/modpathol.2014.95","volume":"28","author":"S Li","year":"2015","unstructured":"Li S, Seegmiller AC, Lin P, Wang XJ, Miranda RN, Bhagavathi S, Medeiros LJ (2015) B-cell lymphomas with concurrent MYC and BCL2 abnormalities other than translocations behave similarly to MYC\/BCL2 double-hit lymphomas. Mod Pathol 28(2):208\u2013217. https:\/\/doi.org\/10.1038\/modpathol.2014.95","journal-title":"Mod Pathol"},{"issue":"6","key":"3050_CR9","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1002\/cncr.26433","volume":"118","author":"P Lin","year":"2012","unstructured":"Lin P, Dickason TJ, Fayad LE, Lennon PA, Hu P, Garcia M, Routbort MJ, Miranda R, Wang X, Qiao W, Medeiros LJ (2012) Prognostic value of MYC rearrangement in cases of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma. Cancer 118(6):1566\u20131573. https:\/\/doi.org\/10.1002\/cncr.26433","journal-title":"Cancer"},{"issue":"1","key":"3050_CR10","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/bjh.12343","volume":"162","author":"AM Perry","year":"2013","unstructured":"Perry AM, Crockett D, Dave BJ, Althof P, Winkler L, Smith LM, Aoun P, Chan WC, Fu K, Greiner TC, Bierman P, Gregory Bociek R, Vose JM, Armitage JO, Weisenburger DD (2013) B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and burkitt lymphoma: Study of 39 cases. Br J Haematol 162(1):40\u201349. https:\/\/doi.org\/10.1111\/bjh.12343","journal-title":"Br J Haematol"},{"issue":"5","key":"3050_CR11","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1111\/j.1365-2559.2012.04301.x","volume":"61","author":"R Kanagal-Shamanna","year":"2012","unstructured":"Kanagal-Shamanna R, Medeiros LJ, Lu G, Wang SA, Manning JT, Lin P, Penn GM, Young KH, You MJ, Vega F, Bassett R, Miranda RN (2012) High-grade B cell lymphoma, unclassifiable, with blastoid features: An unusual morphological subgroup associated frequently with BCL2 and\/or MYC gene rearrangements and a poor prognosis. Histopathology 61(5):945\u2013954. https:\/\/doi.org\/10.1111\/j.1365-2559.2012.04301.x","journal-title":"Histopathology"},{"issue":"8","key":"3050_CR12","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1007\/s00277-011-1162-y","volume":"90","author":"G Vaidyanathan","year":"2011","unstructured":"Vaidyanathan G, Ngamphaiboon N, Hernandez-Ilizaliturri FJ (2011) Clinical spectrum and prognosis of follicular lymphoma with blastoid transformation: Case series and a review of the literature. Ann Hematol 90(8):955\u2013962. https:\/\/doi.org\/10.1007\/s00277-011-1162-y","journal-title":"Ann Hematol"},{"issue":"11","key":"3050_CR13","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1038\/modpathol.2009.106","volume":"22","author":"A Chiu","year":"2009","unstructured":"Chiu A, Frizzera G, Mathew S, Hyjek EM, Chadburn A, Tam W, Knowles DM, Orazi A (2009) Diffuse blastoid B-cell lymphoma: A histologically aggressive variant of t(14;18)-negative follicular lymphoma. Mod Pathol 22(11):1507\u20131517. https:\/\/doi.org\/10.1038\/modpathol.2009.106","journal-title":"Mod Pathol"},{"issue":"14","key":"3050_CR14","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1200\/JCO.2010.32.8385","volume":"29","author":"I Salaverria","year":"2011","unstructured":"Salaverria I, Siebert R (2011) The gray zone between Burkitt\u2019s lymphoma and diffuse large B-cell lymphoma from a genetics perspective. J Clin Oncol 29(14):1835\u20131843. https:\/\/doi.org\/10.1200\/JCO.2010.32.8385","journal-title":"J Clin Oncol"},{"issue":"12","key":"3050_CR15","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1182\/blood-2012-06-435842","volume":"121","author":"H Horn","year":"2013","unstructured":"Horn H, Ziepert M, Becher C, Barth TFE, Bernd H-W, Feller AC, Klapper W, Hummel M, Stein H, Hansmann M-L, Schmelter C, Moller P, Cogliatti S, Pfreundschuh M, Schmitz N, Trumper L, Siebert R, Loeffler M, Rosenwald A, Ott G (2013) MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma. Blood 121(12):2253\u20132263. https:\/\/doi.org\/10.1182\/blood-2012-06-435842","journal-title":"Blood"},{"issue":"22","key":"3050_CR16","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1200\/JCO.2016.70.3660","volume":"35","author":"AM Staiger","year":"2017","unstructured":"Staiger AM, Ziepert M, Horn H, Scott DW, Barth TFE, Bernd H-W, Feller AC, Klapper W, Szczepanowski M, Hummel M, Stein H, Lenze D, Hansmann M-L, Hartmann S, Moller P, Cogliatti S, Lenz G, Trumper L, Loffler M, Schmitz N, Pfreundschuh M, Rosenwald A, Ott G (2017) Clinical Impact of the Cell-of-Origin Classification and the MYC\/ BCL2 Dual Expresser Status in Diffuse Large B-Cell Lymphoma Treated Within Prospective Clinical Trials of the German High-Grade Non-Hodgkin\u2019s Lymphoma Study Group. J Clin Oncol 35(22):2515\u20132526. https:\/\/doi.org\/10.1200\/JCO.2016.70.3660","journal-title":"J Clin Oncol"},{"issue":"2","key":"3050_CR17","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/s41375-019-0573-y","volume":"34","author":"AM Staiger","year":"2020","unstructured":"Staiger AM, Altenbuchinger M, Ziepert M, Kohler C, Horn H, Huttner M, H\u00fcttl KS, Glehr G, Klapper W, Szczepanowski M, Richter J, Stein H, Feller AC, M\u00f6ller P, Hansmann M-L, Poeschel V, Held G, Loeffler M, Schmitz N, Tr\u00fcmper L, Pukrop T, Rosenwald A, Ott G, Spang R (2020) A novel lymphoma-associated macrophage interaction signature (LAMIS) provides robust risk prognostication in diffuse large B-cell lymphoma clinical trial cohorts of the DSHNHL. Leukemia 34(2):543\u2013552. https:\/\/doi.org\/10.1038\/s41375-019-0573-y","journal-title":"Leukemia"},{"key":"3050_CR18","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1182\/blood-2018-07-864025","volume":"133","author":"R Wagener","year":"2018","unstructured":"Wagener R, Seufert J, Raimondi F, Bens S, Kleinheinz K, Nagel I, Altm\u00fcller J, Thiele H, H\u00fcbschmann D, Kohler CW, N\u00fcrnberg P, Au-Yeung R, Burkhardt B, Horn H, Leoncini L, Jaffe ES, Ott G, Rymkiewicz G, Schlesner M, Russell RB, Klapper W, Siebert R (2018) The mutational landscape of Burkitt-like lymphoma with 11q aberration is distinct from that of Burkitt lymphoma. Blood. 133:962\u2013966. https:\/\/doi.org\/10.1182\/blood-2018-07-864025","journal-title":"Blood."},{"issue":"3","key":"3050_CR19","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1182\/blood.V93.3.1124","volume":"93","author":"ES Jaffe","year":"1999","unstructured":"Jaffe ES, Diebold J, Harris NL, Muller-Hermelink HK, Flandrin G, Vardiman JW (1999) Burkitt\u2019s lymphoma: A single disease with multiple variants. The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Blood 93(3):1124","journal-title":"Blood"},{"issue":"23","key":"3050_CR20","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1056\/NEJMoa055351","volume":"354","author":"M Hummel","year":"2006","unstructured":"Hummel M, Bentink S, Berger H, Klapper W, Wessendorf S, Barth TF, Bernd HW, Cogliatti SB, Dierlamm J, Feller AC, Hansmann ML, Haralambieva E, Harder L, Hasenclever D, Kuhn M, Lenze D, Lichter P, Martin-Subero JI, Moller P, Muller-Hermelink HK, Ott G, Parwaresch RM, Pott C, Rosenwald A, Rosolowski M, Schwaenen C, Sturzenhofecker B, Szczepanowski M, Trautmann H, Wacker HH, Spang R, Loeffler M, Trumper L, Stein H, Siebert R (2006) A biologic definition of Burkitt\u2019s lymphoma from transcriptional and genomic profiling. N Engl J Med 354(23):2419\u20132430","journal-title":"N Engl J Med"},{"issue":"23","key":"3050_CR21","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1056\/NEJMoa055759","volume":"354","author":"SS Dave","year":"2006","unstructured":"Dave SS, Fu K, Wright GW, Lam LT, Kluin P, Boerma EJ, Greiner TC, Weisenburger DD, Rosenwald A, Ott G, Muller-Hermelink HK, Gascoyne RD, Delabie J, Rimsza LM, Braziel RM, Grogan TM, Campo E, Jaffe ES, Dave BJ, Sanger W, Bast M, Vose JM, Armitage JO, Connors JM, Smeland EB, Kvaloy S, Holte H, Fisher RI, Miller TP, Montserrat E, Wilson WH, Bahl M, Zhao H, Yang L, Powell J, Simon R, Chan WC, Staudt LM (2006) Molecular diagnosis of Burkitt\u2019s lymphoma. N Engl J Med 354(23):2431\u20132442","journal-title":"N Engl J Med"},{"issue":"11","key":"3050_CR22","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1182\/blood-2013-06-508937","volume":"122","author":"N Masque-Soler","year":"2013","unstructured":"Masque-Soler N, Szczepanowski M, Kohler CW, Spang R, Klapper W (2013) Molecular classification of mature aggressive B-cell lymphoma using digital multiplexed gene expression on formalin-fixed paraffin-embedded biopsy specimens. Blood 122(11):1985\u20131986. https:\/\/doi.org\/10.1182\/blood-2013-06-508937","journal-title":"Blood"},{"issue":"7418","key":"3050_CR23","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/nature11378","volume":"490","author":"R Schmitz","year":"2012","unstructured":"Schmitz R, Young RM, Ceribelli M, Jhavar S, Xiao W, Zhang M, Wright G, Shaffer AL, Hodson DJ, Buras E, Liu X, Powell J, Yang Y, Xu W, Zhao H, Kohlhammer H, Rosenwald A, Kluin P, Muller-Hermelink HK, Ott G, Gascoyne RD, Connors JM, Rimsza LM, Campo E, Jaffe ES, Delabie J, Smeland EB, Ogwang MD, Reynolds SJ, Fisher RI, Braziel RM, Tubbs RR, Cook JR, Weisenburger DD, Chan WC, Pittaluga S, Wilson W, Waldmann TA, Rowe M, Mbulaiteye SM, Rickinson AB, Staudt LM (2012) Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. Nature 490(7418):116\u2013120. https:\/\/doi.org\/10.1038\/nature11378","journal-title":"Nature"},{"issue":"12","key":"3050_CR24","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1038\/ng.2469","volume":"44","author":"J Richter","year":"2012","unstructured":"Richter J, Schlesner M, Hoffmann S, Kreuz M, Leich E, Burkhardt B, Rosolowski M, Ammerpohl O, Wagener R, Bernhart SH, Lenze D, Szczepanowski M, Paulsen M, Lipinski S, Russell RB, Adam-Klages S, Apic G, Claviez A, Hasenclever D, Hovestadt V, Hornig N, Korbel JO, Kube D, Langenberger D, Lawerenz C, Lisfeld J, Meyer K, Picelli S, Pischimarov J, Radlwimmer B, Rausch T, Rohde M, Schilhabel M, Scholtysik R, Spang R, Trautmann H, Zenz T, Borkhardt A, Drexler HG, Moller P, MacLeod RAF, Pott C, Schreiber S, Trumper L, Loeffler M, Stadler PF, Lichter P, Eils R, Kuppers R, Hummel M, Klapper W, Rosenstiel P, Rosenwald A, Brors B, Siebert R (2012) Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing. Nat Genet 44(12):1316\u20131320. https:\/\/doi.org\/10.1038\/ng.2469","journal-title":"Nat Genet"},{"issue":"4","key":"3050_CR25","doi-asserted-by":"publisher","first-page":"726","DOI":"10.3324\/haematol.2013.091827","volume":"99","author":"SM Aukema","year":"2014","unstructured":"Aukema SM, Kreuz M, Kohler CW, Rosolowski M, Hasenclever D, Hummel M, Kuppers R, Lenze D, Ott G, Pott C, Richter J, Rosenwald A, Szczepanowski M, Schwaenen C, Stein H, Trautmann H, Wessendorf S, Trumper L, Loeffler M, Spang R, Kluin PM, Klapper W, Siebert R (2014) Biological characterization of adult MYC-translocation-positive mature B-cell lymphomas other than molecular Burkitt lymphoma. Haematologica 99(4):726\u2013735. https:\/\/doi.org\/10.3324\/haematol.2013.091827","journal-title":"Haematologica"},{"issue":"11","key":"3050_CR26","first-page":"4771","volume":"33","author":"N Gebauer","year":"2013","unstructured":"Gebauer N, Bernard V, Feller AC, Merz H (2013) ID3 mutations are recurrent events in double-hit B-cell lymphomas. Anticancer Res 33(11):4771\u20134778","journal-title":"Anticancer Res"},{"issue":"8","key":"3050_CR27","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1038\/leu.2015.34","volume":"29","author":"S Momose","year":"2015","unstructured":"Momose S, Weissbach S, Pischimarov J, Nedeva T, Bach E, Rudelius M, Geissinger E, Staiger AM, Ott G, Rosenwald A (2015) The diagnostic gray zone between Burkitt lymphoma and diffuse large B-cell lymphoma is also a gray zone of the mutational spectrum. Leukemia 29(8):1789\u20131791. https:\/\/doi.org\/10.1038\/leu.2015.34","journal-title":"Leukemia"},{"issue":"6","key":"3050_CR28","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1111\/bjh.13501","volume":"170","author":"SM Aukema","year":"2015","unstructured":"Aukema SM, Theil L, Rohde M, Bauer B, Bradtke J, Burkhardt B, Bonn BR, Claviez A, Gattenl\u00f6hner S, Makarova O, Nagel I, Oschlies I, Pott C, Szczepanowski M, Traulsen A, Kluin PM, Klapper W, Siebert R, Murga Penas EM (2015) Sequential karyotyping in Burkitt lymphoma reveals a linear clonal evolution with increase in karyotype complexity and a high frequency of recurrent secondary aberrations. Br J Haematol 170(6):814\u2013825. https:\/\/doi.org\/10.1111\/bjh.13501","journal-title":"Br J Haematol"},{"issue":"1","key":"3050_CR29","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/bjh.13925","volume":"173","author":"V Havelange","year":"2016","unstructured":"Havelange V, Pepermans X, Ameye G, Th\u00e9ate I, Callet-Bauchu E, Barin C, Penther D, Lippert E, Michaux L, Mugneret F, Dastugue N, Rapha\u00ebl M, Vikkula M, Poirel HA (2016) Genetic differences between paediatric and adult Burkitt lymphomas. Br J Haematol 173(1):137\u2013144. https:\/\/doi.org\/10.1111\/bjh.13925","journal-title":"Br J Haematol"},{"issue":"4","key":"3050_CR30","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1002\/path.1596","volume":"203","author":"TFE Barth","year":"2004","unstructured":"Barth TFE, M\u00fcller S, Pawlita M, Siebert R, Rother JU, Mechtersheimer G, Kitinya J, Bentz M, M\u00f6ller P (2004) Homogeneous immunophenotype and paucity of secondary genomic aberrations are distinctive features of endemic but not of sporadic Burkitt\u2019s lymphoma and diffuse large B-cell lymphoma with MYC rearrangement. J Pathol 203(4):940\u2013945. https:\/\/doi.org\/10.1002\/path.1596","journal-title":"J Pathol"},{"issue":"8","key":"3050_CR31","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1097\/01.pas.0000168176.71405.e5","volume":"29","author":"E Haralambieva","year":"2005","unstructured":"Haralambieva E, Boerma EJ, van Imhoff GW, Rosati S, Schuuring E, Muller-Hermelink HK, Kluin PM, Ott G (2005) Clinical, immunophenotypic, and genetic analysis of adult lymphomas with morphologic features of Burkitt lymphoma. Am J Surg Pathol 29(8):1086\u20131094","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"3050_CR32","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1093\/ajcp\/112.6.828","volume":"112","author":"CW Lin","year":"1999","unstructured":"Lin CW, O\u2019Brien S, Faber J, Manshouri T, Romaguera J, Huh YO, Kantarjian H, Keating M, Albitar M (1999) De novo CD5+ Burkitt lymphoma\/leukemia. Am J Clin Pathol 112(6):828\u2013835. https:\/\/doi.org\/10.1093\/ajcp\/112.6.828","journal-title":"Am J Clin Pathol"},{"issue":"4","key":"3050_CR33","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1111\/bjh.13624","volume":"171","author":"N Masqu\u00e9-Soler","year":"2015","unstructured":"Masqu\u00e9-Soler N, Szczepanowski M, Kohler CW, Aukema SM, Nagel I, Richter J, Siebert R, Spang R, Burkhardt B, Klapper W (2015) Clinical and pathological features of Burkitt lymphoma showing expression of BCL2--an analysis including gene expression in formalin-fixed paraffin-embedded tissue. Br J Haematol 171(4):501\u2013508. https:\/\/doi.org\/10.1111\/bjh.13624","journal-title":"Br J Haematol"},{"issue":"8","key":"3050_CR34","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1182\/blood-2013-06-507996","volume":"123","author":"I Salaverria","year":"2014","unstructured":"Salaverria I, Martin-Guerrero I, Wagener R, Kreuz M, Kohler CW, Richter J, Pienkowska-Grela B, Adam P, Burkhardt B, Claviez A, Damm-Welk C, Drexler HG, Hummel M, Jaffe ES, Kuppers R, Lefebvre C, Lisfeld J, Loffler M, MacLeod RAF, Nagel I, Oschlies I, Rosolowski M, Russell RB, Rymkiewicz G, Schindler D, Schlesner M, Scholtysik R, Schwaenen C, Spang R, Szczepanowski M, Trumper L, Vater I, Wessendorf S, Klapper W, Siebert R (2014) A recurrent 11q aberration pattern characterizes a subset of MYC-negative high-grade B-cell lymphomas resembling Burkitt lymphoma. Blood 123(8):1187\u20131198. https:\/\/doi.org\/10.1182\/blood-2013-06-507996","journal-title":"Blood"},{"issue":"18","key":"3050_CR35","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1182\/blood.2019002600","volume":"134","author":"LK Hilton","year":"2019","unstructured":"Hilton LK, Tang J, Ben-Neriah S, Alcaide M, Jiang A, Grande BM, Rushton CK, Boyle M, Meissner B, Scott DW, Morin RD (2019) The double-hit signature identifies double-hit diffuse large B-cell lymphoma with genetic events cryptic to FISH. Blood 134(18):1528\u20131532. https:\/\/doi.org\/10.1182\/blood.2019002600","journal-title":"Blood"},{"issue":"4","key":"3050_CR36","doi-asserted-by":"publisher","first-page":"e202","DOI":"10.3324\/haematol.2018.208140","volume":"105","author":"R Wagener","year":"2020","unstructured":"Wagener R, Bens S, Toprak UH, Seufert J, L\u00f3pez C, Scholz I, Herbrueggen H, Oschlies I, Stilgenbauer S, Schlesner M, Klapper W, Burkhardt B, Siebert R (2020) Cryptic insertion of MYC exons 2 and 3 into the immunoglobulin heavy chain locus detected by whole genome sequencing in a case of \u201cMYC-negative\u201d Burkitt lymphoma. Haematologica 105(4):e202\u2013e205. https:\/\/doi.org\/10.3324\/haematol.2018.208140","journal-title":"Haematologica"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-021-03050-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-021-03050-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-021-03050-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,18]],"date-time":"2021-09-18T01:24:08Z","timestamp":1631928248000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-021-03050-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,2]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["3050"],"URL":"https:\/\/doi.org\/10.1007\/s00428-021-03050-4","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,2]]},"assertion":[{"value":"27 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All authors gave consent to publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}